Adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes who are not adequately controlled on metformin or sitagliptin alone or in patients already being treated with ...

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)-- Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) approved JANUMET ® XR ...

If you have type 2 diabetes, your doctor might suggest Janumet or Janumet XR as a treatment option for you. Janumet and Janumet XR are prescription drugs that are prescribed along with exercise and a ...

For some patients newly diagnosed with type 2 diabetes, skipping metformin monotherapy and going straight to fixed-dose combinations with a DPP-4 inhibitor or an SGLT2 inhibitor makes sense, evidence ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved a once-daily, fixed-dose combination therapy of the SGLT2 inhibitor canagliflozin and ...

Dear Dr. Roach: I’ve been diagnosed with Type 2 diabetes and prescribed 1,500 mg of metformin. My A1C is now 6.0, although even when it was 5.8, my endocrinologist kept the same dosage. My primary ...